WELCOME TO The HEALTHCARE REPORT
Newsletter | Member Login | Signup
Home > Companies > BayCare Clinic
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Medical News | April 01, 2020
Randox Laboratories is partnering with the government to develop a new coronavirus testing program in which NHS staff will be first in line. The new service, which will be free, will help to end the uncertainty of whether NHS staff need to stay at home. Those who test negative for coronavirus will be able to return to work – enhancing the capacity of the NHS and social care to treat patients and care for those in community settings, with plans for a full roll-out for health, social care and othe...
Digital Healthcare, Medical Devices
WELL Health Technologies Corp. | April 27, 2023
WELL Ventures a subsidiary of WELL Health Technologies Corp. a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce the launch of a new investment program, The WELL AI Investment Program, focused on artificial intelligence ("AI") and its applications in helping support healthcare providers with next generation tools . The WELL AI Invest...
Future of Healthcare
Skylight Health Group | December 14, 2022
Skylight Health Group Inc. a healthcare platform combining technology and analytics focused on transitioning patients into value based care to drive better health outcomes and experiences in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares for the month of January 2023. The Series A Preferred Shares trade under the “SLHGP” stock ticker symbol....
HIT Consultant | March 13, 2020
The Bill & Melinda Gates Foundation, Wellcome and Mastercard announced the launch of the COVID-19 Therapeutics Accelerator with a committed $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. While antiviral drugs are approved to lessen the severity of seasonal flu and treat HI...
Healthtech Security
Article
Digital Healthcare
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE